Dexcom (DXCM) Inventory Average (2011 - 2026)

Dexcom (DXCM) has 16 years of Inventory Average data on file, last reported at $661.4 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 22.38% year-over-year to $661.4 million in Q1 2026; TTM through Mar 2026 was $661.4 million, a 22.38% increase from a year earlier, with the FY2025 full-year figure at $585.8 million, up 6.31% from the prior year.
• Inventory Average for Q1 2026 stood at $661.4 million, up from $616.6 million in the prior quarter.
• Over the last five years, Inventory Average for DXCM reached as high as $661.4 million in Q1 2026 and fell as low as $308.8 million in Q4 2022.
• Historically, Inventory Average has averaged $488.3 million across 5 years, with a median of $540.4 million in 2025.
• Across the five-year window, Inventory Average decreased 12.83% in 2022 and soared 71.31% in 2023, its largest moves.
• Year by year, Inventory Average stood at $308.8 million in 2022, then surged by 71.31% to $529.1 million in 2023, then increased by 6.68% to $564.4 million in 2024, then climbed by 9.24% to $616.6 million in 2025, then advanced by 7.26% to $661.4 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $661.4 million in Q1 2026, $616.6 million in Q4 2025, and $587.4 million in Q3 2025.